乳腺肿块超声「回声晕」作为恶性独立诊断与预后标志的价值
本研究回顾性比较活检证实的恶性乳腺肿块有无回声晕的影像与表型特征,并单独评估活检为DCIS肿块中回声晕与手术升级为浸润癌的关系。结果显示回声晕与浸润性乳腺癌相关,且DCIS升级率更高,但在其他诊断或预后方面价值有限。
要点
- 肿块周边回声晕与浸润性乳腺癌相关,见到时应提高对浸润性癌的警惕。
- 粗针活检为DCIS且肿块有回声晕时,手术病理升级为浸润癌的可能性更高。
- 回声晕不反映肿块大小、形态、边缘、受体状态或Nottingham分级差异。
核心结论
- 肿块周边出现回声晕与浸润性恶性肿瘤相关,并与DCIS手术升级为浸润癌相关。
- 回声晕在受体状态、Nottingham分级及肿瘤形态学方面未显示额外诊断或预后价值。
研究设计与样本
- 回顾性队列研究,对连续活检证实的恶性乳腺肿块按有无回声晕分组比较。
- 回声晕定义为环绕肿块至少25%周长且厚度≥1 mm、破坏邻近组织的回声带。
- 另独立纳入连续活检证实的DCIS肿块队列,评估手术病理升级为浸润癌的比例。
- 组间比较采用Fisher精确检验及多因素分析。
关键影像表现/征象
- 回声晕表现为肿块周边厚度≥1 mm的回声带,包绕至少25%的肿块周长并可破坏邻近组织结构。
- 有回声晕的恶性肿块在大小、形状、边缘及方位方面与无回声晕组无显著差异。
诊断标准与关键数值
- 有回声晕的肿块与浸润性乳腺癌相关,P = 0.001。
- 粗针活检提示DCIS的肿块中,有回声晕者手术病理升级为浸润癌的比例更高,P = 0.04。
- 两组肿块大小比较P = 0.41,形状比较P = 0.44,边缘比较P = 0.62。
- 受体状态组间比较P = 0.98,Nottingham分级组间比较P = 0.85。
临床应用与阅片要点
- 超声扫查乳腺肿块时,应观察并描述是否伴有符合定义的回声晕,记录其包绕比例与最厚径。
- 对有回声晕的肿块,若粗针活检报告为DCIS,应提示手术病理有升级为浸润癌的可能。
- 报告回声晕时不应默认提示临床分期更晚或分级更高,需结合其他影像与病理特征综合判断。
局限性
- 研究为回顾性设计。
- 回声晕的判定依赖操作者经验,存在观察者间差异的可能。
- 样本来自单中心连续病例,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Echogenic rind has been incorporated into the BI-RADS v2025 ultrasound lexicon as an associated feature of masses; however, its utility as an independent diagnostic and prognostic marker of malignancy has not been well established. This retrospective study compares the imaging and phenotypic features of biopsy-proven malignant masses with and without an echogenic rind to assess its utility as an imaging marker.
MATERIALS AND METHODS: Consecutive patients with biopsy-proven malignant masses were placed into separate cohorts based on the presence/absence of an echogenic rind. An echogenic rind was defined as an ≥1 mm echogenic band that surrounded at least 25% of the mass circumference and disrupted adjacent tissue. Imaging characteristics (size, shape, margins, orientation), tumor type (ductal carcinoma in situ [DCIS], invasive ductal carcinoma, and invasive lobular carcinoma), receptor status, and Nottingham grades of masses in both cohorts were compared using Fisher's exact test and multivariate analysis. A separate cohort of consecutive patients with biopsy-proven DCIS presenting as masses was then reviewed to assess the proportion of masses with an echogenic rind and upgrade to invasive malignancy on surgical pathology.
RESULTS: Masses with an echogenic rind were associated with invasive breast cancer (P = 0.001) and had higher upgrade rates when core biopsy revealed DCIS (P = 0.04). Masses in both cohorts did not vary by size (P = 0.41), shape (P = 0.44), or margin (P = 0.62), or demonstrate significant differences in receptor status (P = 0.98) or Nottingham grade (P = 0.85).
CONCLUSION: Presence of an echogenic rind surrounding a mass is associated with invasive malignancy and correlates with upgrade of DCIS to invasive cancer on surgical pathology but otherwise offers minimal additional diagnostic or prognostic utility to radiologists.
引用
- Matari, Khilnani, Slanetz, et al. Echogenic Rind as an Independent Diagnostic and Prognostic Marker of Malignancy. Acad Radiol. 2026. PMID: 42823314. doi:10.1016/j.acra.2026.09.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。